These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 19835859)

  • 21. β-1,3-Galactosyl-
    Sumardika IW; Youyi C; Kondo E; Inoue Y; Ruma IMW; Murata H; Kinoshita R; Yamamoto KI; Tomida S; Shien K; Sato H; Yamauchi A; Futami J; Putranto EW; Hibino T; Toyooka S; Nishibori M; Sakaguchi M
    Oncol Res; 2018 Apr; 26(3):431-444. PubMed ID: 28923134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells.
    Hermani A; De Servi B; Medunjanin S; Tessier PA; Mayer D
    Exp Cell Res; 2006 Jan; 312(2):184-97. PubMed ID: 16297907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies.
    Wagner NB; Weide B; Gries M; Reith M; Tarnanidis K; Schuermans V; Kemper C; Kehrel C; Funder A; Lichtenberger R; Sucker A; Herpel E; Holland-Letz T; Schadendorf D; Garbe C; Umansky V; Utikal J; Gebhardt C
    J Immunother Cancer; 2019 Dec; 7(1):343. PubMed ID: 31806053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. S100A8/A9 activate key genes and pathways in colon tumor progression.
    Ichikawa M; Williams R; Wang L; Vogl T; Srikrishna G
    Mol Cancer Res; 2011 Feb; 9(2):133-48. PubMed ID: 21228116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of serum proteins that bind with S100A8, S100A9 and S100A8/A9: clinical significance of using proteins for monitoring the postoperative condition of liver recipients.
    Namura T; Arai S; Okawa K; Koike A; Yamada S; Saita N; Nagae A; Itoh H; Totani M; Uemoto S; Ikemoto M
    Clin Chim Acta; 2010 Nov; 411(21-22):1766-73. PubMed ID: 20674560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Up-regulation of S100A8 and S100A9 protein in bronchial epithelial cells by lipopolysaccharide.
    Henke MO; Renner A; Rubin BK; Gyves JI; Lorenz E; Koo JS
    Exp Lung Res; 2006 Sep; 32(8):331-47. PubMed ID: 17090475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer.
    Ehrchen JM; Sunderkötter C; Foell D; Vogl T; Roth J
    J Leukoc Biol; 2009 Sep; 86(3):557-66. PubMed ID: 19451397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular basis of the complex formation between the two calcium-binding proteins S100A8 (MRP8) and S100A9 (MRP14).
    Leukert N; Sorg C; Roth J
    Biol Chem; 2005 May; 386(5):429-34. PubMed ID: 15927886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. S100A8/A9 promotes parenchymal damage and renal fibrosis in obstructive nephropathy.
    Tammaro A; Florquin S; Brok M; Claessen N; Butter LM; Teske GJD; de Boer OJ; Vogl T; Leemans JC; Dessing MC
    Clin Exp Immunol; 2018 Sep; 193(3):361-375. PubMed ID: 29746703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis.
    Hiratsuka S; Watanabe A; Aburatani H; Maru Y
    Nat Cell Biol; 2006 Dec; 8(12):1369-75. PubMed ID: 17128264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The response of the novel pro-inflammatory molecules S100A8/A9 to exercise.
    Mooren FC; Lechtermann A; Fobker M; Brandt B; Sorg C; Völker K; Nacken W
    Int J Sports Med; 2006 Sep; 27(9):751-8. PubMed ID: 16944403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcium-dependent tetramer formation of S100A8 and S100A9 is essential for biological activity.
    Leukert N; Vogl T; Strupat K; Reichelt R; Sorg C; Roth J
    J Mol Biol; 2006 Jun; 359(4):961-72. PubMed ID: 16690079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding.
    Ruma IM; Putranto EW; Kondo E; Murata H; Watanabe M; Huang P; Kinoshita R; Futami J; Inoue Y; Yamauchi A; Sumardika IW; Youyi C; Yamamoto K; Nasu Y; Nishibori M; Hibino T; Sakaguchi M
    Clin Exp Metastasis; 2016 Aug; 33(6):609-27. PubMed ID: 27151304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrinsic function of S100A8/A9 complex as an anti-inflammatory protein in liver injury induced by lipopolysaccharide in rats.
    Ikemoto M; Murayama H; Itoh H; Totani M; Fujita M
    Clin Chim Acta; 2007 Feb; 376(1-2):197-204. PubMed ID: 17011539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. S100A9 has a protective role in inflammation-induced skin carcinogenesis.
    McNeill E; Hogg N
    Int J Cancer; 2014 Aug; 135(4):798-808. PubMed ID: 24436096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. S100A8/9 induces cell death via a novel, RAGE-independent pathway that involves selective release of Smac/DIABLO and Omi/HtrA2.
    Ghavami S; Kerkhoff C; Chazin WJ; Kadkhoda K; Xiao W; Zuse A; Hashemi M; Eshraghi M; Schulze-Osthoff K; Klonisch T; Los M
    Biochim Biophys Acta; 2008 Feb; 1783(2):297-311. PubMed ID: 18060880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-10-dependent S100A8 gene induction in monocytes/macrophages by double-stranded RNA.
    Endoh Y; Chung YM; Clark IA; Geczy CL; Hsu K
    J Immunol; 2009 Feb; 182(4):2258-68. PubMed ID: 19201880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. S100A8/A9 stimulates keratinocyte proliferation in the development of squamous cell carcinoma of the skin via the receptor for advanced glycation-end products.
    Iotzova-Weiss G; Dziunycz PJ; Freiberger SN; Läuchli S; Hafner J; Vogl T; French LE; Hofbauer GF
    PLoS One; 2015; 10(3):e0120971. PubMed ID: 25811984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Melanoma cell adhesion molecule is the driving force behind the dissemination of melanoma upon S100A8/A9 binding in the original skin lesion.
    Chen Y; Sumardika IW; Tomonobu N; Winarsa Ruma IM; Kinoshita R; Kondo E; Inoue Y; Sato H; Yamauchi A; Murata H; Yamamoto KI; Tomida S; Shien K; Yamamoto H; Soh J; Liu M; Futami J; Sasai K; Katayama H; Kubo M; Putranto EW; Hibino T; Sun B; Nishibori M; Toyooka S; Sakaguchi M
    Cancer Lett; 2019 Jun; 452():178-190. PubMed ID: 30904617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. S100A8/A9 (calprotectin) negatively regulates G2/M cell cycle progression and growth of squamous cell carcinoma.
    Khammanivong A; Wang C; Sorenson BS; Ross KF; Herzberg MC
    PLoS One; 2013; 8(7):e69395. PubMed ID: 23874958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.